U.S. Healthtech Stock News

NYSE:BMY
NYSE:BMYPharmaceuticals

Does Expanded MTAP-CDx Partnership With Foundation Medicine Change The Bull Case For Bristol-Myers Squibb (BMY)?

Earlier this month, Foundation Medicine announced an expanded collaboration with Bristol-Myers Squibb to develop FoundationOne CDx as a next-generation sequencing-based companion diagnostic to identify patients with homozygous MTAP deletion for an investigational targeted cancer therapy. This move underlines Bristol-Myers Squibb’s push deeper into precision oncology, where better patient selection tools could enhance the impact and utilization of its future therapies. Next, we’ll examine how...
NYSE:AVEX
NYSE:AVEXAerospace & Defense

Assessing AEVEX (AVEX) Valuation After Recent Share Price Weakness

AEVEX stock reaction and recent price performance AEVEX (AVEX) shares closed at $29.90, with the stock showing an 11.9% decline over the past day and a 16.9% decline over the past week, while year-to-date performance remains positive. See our latest analysis for AEVEX. The sharp 1 day share price return of negative 11.9% and 7 day share price return of negative 16.9% sit against a year to date share price return of 11%, suggesting that recent momentum has cooled after earlier gains. If you...
NYSE:MKL
NYSE:MKLInsurance

Assessing Markel Group (MKL) Valuation As Shares Trade Below Analyst Targets And Narrative Fair Value

Markel Group (MKL) has recently attracted investor interest after its shares closed at US$1,908.99. With a market value of about US$23.8b, the diversified insurance and investment company offers a mix of underwriting and non-insurance businesses. See our latest analysis for Markel Group. Recent trading has been mixed, with a 0.70% 1 day share price gain alongside a 10.39% year to date share price decline. Meanwhile, 1 year total shareholder return of 4.89% and 5 year total shareholder return...
NYSE:LEVI
NYSE:LEVILuxury

Levi Strauss Board Shakeup Meets Direct To Consumer Growth Story

Levi Strauss (NYSE:LEVI) has appointed Troy Alstead as its next board chair, succeeding Robert Eckert as he steps down. Director Chris McCormick is retiring from the board as part of the latest governance changes. The company reported Q1 growth with rising direct to consumer revenue now accounting for more than 50% of sales, alongside global brand initiatives. For investors tracking NYSE:LEVI, these leadership shifts arrive alongside a share price of $22.3 and a 45.1% gain over the past...
NYSE:IQV
NYSE:IQVLife Sciences

Is It Time To Revisit IQVIA (IQV) After Its Sharp Year To Date Share Price Drop

If you are wondering whether IQVIA Holdings is priced fairly or if the recent share price is offering you an opening, this article focuses squarely on what the current valuation is indicating. The stock last closed at US$158.98, with returns of 3.6% over 1 year, but year to date the share price is down 29.5%. This includes a 9.5% fall over the past week and a 3% decline over the past month. These moves sit against a longer backdrop where the stock shows a 14.3% decline over 3 years and a...
NasdaqGS:PLTR
NasdaqGS:PLTRSoftware

A Look At Palantir Technologies (PLTR) Valuation After Its New US$300 Million USDA Agreement

Palantir Technologies (PLTR) just secured a multi year, US$300 million agreement with the U.S. Department of Agriculture to support the National Farm Security Action Plan and modernize service delivery for farmers. See our latest analysis for Palantir Technologies. Despite the USDA agreement and other recent contracts across government and commercial clients, momentum in Palantir's shares has cooled, with a 90 day share price return showing a decline of 10.28% and a year to date share price...
NasdaqGM:HLMN
NasdaqGM:HLMNMachinery

Hillman Solutions (HLMN) Quarterly Loss Tests Bullish Margin Expansion Narrative

Hillman Solutions (HLMN) opened Q1 2026 with revenue of US$370.1 million and basic EPS of a US$0.02 loss, compared with US$359.3 million of revenue and a near breakeven EPS of a US$0.00 loss in Q1 2025. Over the last year, the company has seen revenue move from US$1.48 billion to US$1.56 billion on a trailing twelve month basis, while trailing EPS shifted from US$0.09 to US$0.18. This puts the latest quarter into a context of expanding earnings power. For investors, the mix of higher trailing...
NasdaqGM:LUNR
NasdaqGM:LUNRAerospace & Defense

Is It Too Late To Consider Intuitive Machines (LUNR) After Its Recent Lunar Contract Headlines?

If you are wondering whether Intuitive Machines at around US$24.58 is still offering value after a big run, you are not alone. This article focuses squarely on what that price may or may not reflect. The stock has been volatile, with an 11.6% decline over the last 7 days contrasted against gains of 40.3% over 30 days, 37.5% year to date and 185.8% over the past year. Recent news coverage has centred on Intuitive Machines' role in the growing commercial space sector and its exposure to high...
NYSE:AR
NYSE:AROil and Gas

Is It Time To Reconsider Antero Resources (AR) After The Recent 30 Day Pullback

If you are wondering whether Antero Resources at around US$38.55 is offering value or asking you to pay up, this breakdown will help you put the recent share price into context. The stock closed at US$38.55, with a 3.7% return over the last 7 days, a 14.6% decline over 30 days, a 12.7% return year to date, a 6.6% return over 1 year, an 82.6% return over 3 years and a very large 5 year return that is roughly 3x. Recent coverage has focused on broader energy sector trends and changing investor...
NasdaqGS:CALM
NasdaqGS:CALMFood

Is It Time To Revisit Cal-Maine Foods (CALM) After Egg Market Headlines?

Investors may be wondering whether Cal-Maine Foods at around US$77 a share still offers value, or if most of the easy gains are already behind it. The stock has barely moved over the past week and month, with returns of 0.3% over 7 days and 0.2% over 30 days, while the 1 year return of a 12.9% decline contrasts with a 166.7% gain over 5 years. Recent headlines have focused on Cal-Maine Foods' role in the egg market and how pricing, supply trends, and consumer demand continue to frame the...
NYSE:ROG
NYSE:ROGElectronic

Assessing Rogers (ROG) Valuation After A Strong Year Of Shareholder Returns

Why Rogers (ROG) is Back on Investor Radar Rogers (ROG) has been drawing fresh attention after a period of strong share price performance, with the stock showing double digit total returns over the past year and year to date. See our latest analysis for Rogers. The recent 18.38% 1 month share price return and 34.73% 3 month share price return, alongside a 117.77% 1 year total shareholder return, suggest momentum has shifted sharply, although the 3 and 5 year total shareholder returns remain...
NYSE:C
NYSE:CBanks

Did Citi's (C) AI-Powered Wealth Push and Debt Issuance Just Reframe Its Investment Narrative?

In recent weeks, Citigroup Inc. completed several fixed-income offerings across various maturities while Citi Wealth introduced Citi Sky, an AI-powered assistant built with Google Cloud and Google DeepMind to enhance U.S. client engagement, and announced a Global Unified Managed Account program in partnership with Advyzon and BlackRock-powered Citi Portfolio Solutions. These moves, alongside new leadership appointments in commercial and private company coverage and Citi’s leading role in...
NYSE:BWXT
NYSE:BWXTAerospace & Defense

Should BWX Technologies’ Capacity-Boosting Acquisition Shape BWXT Investors’ View of Its Risk-Reward Profile?

In April 2026, BWX Technologies announced it would acquire Precision Components Group, adding more than 500,000 square feet of US heavy-manufacturing capacity and over 400 skilled employees to its Commercial Operations segment, while keeping the acquired business at its existing facilities. Ahead of its upcoming quarterly results, BWX Technologies has drawn attention as analysts highlight a strong record of earnings outperformance and forecast the potential for another earnings beat,...
NasdaqGS:IAC
NasdaqGS:IACInteractive Media and Services

Assessing IAC (IAC) Valuation After Recent Share Price Moves And Mixed Growth Signals

IAC (IAC) recently caught investor attention after its latest trading session, with shares closing at US$44.08. The move comes against a backdrop of mixed recent returns across different time frames. See our latest analysis for IAC. While the share price slipped 1.17% over the last session and 1.54% across the week, the 30 day share price return of 13.46% and 1 year total shareholder return of 23.16% point to improving momentum despite a weak 5 year total shareholder return of 66.50%. If...
NYSE:CAT
NYSE:CATMachinery

Assessing Caterpillar (CAT) Valuation After A Strong Multi‑Period Share Price Run

Why Caterpillar stock is on investors’ radar Caterpillar (CAT) has drawn fresh attention after recently trading around $817.87, with returns over the past month and past 3 months far outpacing its 1-day move. With a market value near $386b and annual revenue of about $67.6b, the company’s scale across construction, mining, energy, transportation, and financial services gives investors several business segments to assess. See our latest analysis for Caterpillar. While the 1 day share price...
NYSE:BFLY
NYSE:BFLYMedical Equipment

A Look At Butterfly Network (BFLY) Valuation After Appointing Dr. Arun Nagdev As Chief Medical Officer

Butterfly Network (BFLY) recently appointed Arun Nagdev, MD as Chief Medical Officer for Point of Care Ultrasound, placing a seasoned clinician and ultrasound specialist at the center of its global medical and product validation strategy. See our latest analysis for Butterfly Network. The appointment of Dr. Nagdev comes as Butterfly Network’s 1 month share price return of 31.63% and 90 day share price return of 19.72% contrast with a 5 day pullback, while the 1 year total shareholder return...
NYSE:NRP
NYSE:NRPOil and Gas

How NRP’s Rapid Deleveraging and Cash Returns Strategy Could Reshape Natural Resource Partners Investors’ Outlook

Recent commentary on Natural Resource Partners L.P. highlights growing investor interest in its royalty-focused business model, ongoing debt reduction, and emphasis on returning cash to unitholders through distributions and buybacks. An interesting angle for investors is the prospect of the partnership approaching near net-zero debt while potentially layering in additional special distributions over time. With this backdrop, we will explore how Natural Resource Partners’ accelerated debt...
NasdaqGS:HNVR
NasdaqGS:HNVRBanks

Hanover Bancorp (HNVR) Net Interest Margin Rebound Tests Bullish Growth Narrative

Hanover Bancorp (HNVR) opened Q1 2026 with total revenue of US$18.6 million and basic EPS of US$0.25, alongside trailing 12 month revenue of US$63.8 million and basic EPS of US$1.05. Over recent quarters, revenue has moved between US$17.6 million in Q4 2024, US$17.8 million in Q1 2025 and US$16.0 million to US$18.6 million through 2025 and into Q1 2026. Quarterly EPS has ranged from US$0.51 in Q4 2024 to US$0.20, US$0.33, US$0.47 and US$0.01 across 2025 before landing at US$0.25 this quarter...
NYSEAM:UEC
NYSEAM:UECOil and Gas

Should Burke Hollow ISR Approval Reshape Uranium Energy’s (UEC) U.S. Nuclear Fuel Strategy?

Uranium Energy Corp recently received approval from the Texas Commission on Environmental Quality to begin operations at its Burke Hollow in-situ recovery uranium project, the first new ISR uranium operation to launch in the United States in over a decade. This regulatory milestone strengthens Uranium Energy’s position in U.S.-sourced nuclear fuel and could influence how investors view its long-term production profile. We’ll now examine how Burke Hollow’s newly approved ISR operations could...
NYSE:AXS
NYSE:AXSInsurance

A Look At AXIS Capital Holdings’s Valuation After Recent Share Price Moves

Why AXIS Capital Holdings (NYSE:AXS) Is On Investors’ Radar AXIS Capital Holdings (NYSE:AXS) is drawing attention after recent share price moves, with the stock around $100.35 and mixed short term returns across the past week, month, and past 3 months. See our latest analysis for AXIS Capital Holdings. At around $100.35 per share, AXIS Capital Holdings has seen mixed short term share price returns, while its 1 year and multi year total shareholder returns of 5.47%, 92.73%, and 99.93% point to...
NYSE:ARE
NYSE:AREHealth Care REITs

Alexandria Real Estate Equities (ARE) Sees Q1 FFO Surge Questioning Bearish Cash Flow Narratives

Alexandria Real Estate Equities (ARE) opened 2026 with Q1 funds from operations of US$636.9 million, basic EPS of US$2.10 and total revenue of US$670.9 million, setting a fresh reference point after a volatile stretch of results in 2025. Over recent quarters, revenue has moved from US$795.6 million in Q4 2024 to a range between US$752.1 million and US$757.7 million across 2025 before landing at US$670.9 million in Q1 2026, while basic EPS has swung from a loss of US$0.38 in Q4 2024 to a loss...
NYSE:HLT
NYSE:HLTHospitality

Hilton (HLT) Margin Compression Challenges Bullish Growth Narrative After Q1 2026 Results

Hilton Worldwide Holdings (HLT) opened 2026 with Q1 revenue of US$2.9b and basic EPS of US$1.68, setting the tone for how its fee driven model is translating into bottom line results. Over the last five reported quarters, revenue has ranged from US$1.1b to US$2.9b while basic EPS moved between US$1.25 and US$2.08, giving investors a clear view of how earnings have tracked alongside a growing top line. With trailing net profit margins reported at 29.7%, down from 33% a year earlier, this...
NYSE:PRU
NYSE:PRUInsurance

A Look At Prudential Financial (PRU) Valuation After Recent Mixed Share Price Performance

Key performance snapshot for Prudential Financial Prudential Financial (PRU) has seen mixed share performance, with the stock up over the past month but showing a decline over the past 3 months and year to date, which can prompt investors to reassess the risk reward tradeoffs. The company reports revenue of US$61,233.0m and net income of US$3,535.0m, with annual revenue and net income growth figures both positive. This can offer a reference point as you compare current pricing to recent...
NasdaqGS:WAY
NasdaqGS:WAYHealthcare Services

Waystar Holding (WAY) Valuation Check As New AltitudeAI Capabilities And Google Cloud Tie Up Gain Traction

Waystar Holding (WAY) has put its AI ambitions front and center, rolling out new AltitudeAI capabilities that target healthcare revenue cycle automation, silent denials, revenue leakage, and personalized patient billing, supported by an expanded Google Cloud collaboration. See our latest analysis for Waystar Holding. Despite the recent AltitudeAI launch and conference activity, Waystar Holding’s 1-month share price return of 7.54% comes alongside a year-to-date share price return of 19.57%...